Skip to content

DR. L. ONKELINX

Active Private limited companyfounded 2008active for 18 yearsOnderwijsstraat 8, 2540 HoveKBO/BCE: BE 0895.851.319

Lifetime

18 annual accounts with figures on one time axis
peak of €240,569 in 2016
€168,510▼ 26.7%
lowest -€22,060 in 2022
€107,126▼ 24.8%
peak of €670,953 in 2021
€451,887▲ 12.8%
€96,207▼ 37.5%
Board1 name since 2020
1 director
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Gross margin from €229,925 to €168,510Dividend €55,907Equity from €400,668 to €451,887Debts from €153,949 to €96,207

Key points

from the 2025 annual accounts

Equity

€451,887 ▲ 12.8%
400,6682024+107,126Profit-55,907Dividend451,8872025

DR. L. ONKELINX paid out €55,907 in dividends. That is 52% of the 2025 profit.

Liquidity

5.13 was 3.20 in 2024

Short-term debts fell from €146,851 to €92,020.

Filings

18 annual accounts since 2008
AprilJune31 JulyOctober2010201520202025

Three of the last ten came late. The 2016 accounts came in latest, 30 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,816 companies had the same profile as DR. L. ONKELINX has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,816 companies, not a prediction for DR. L. ONKELINX. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

reappointed as director General meeting of 30-08-2023 · Gazette deed
reappointed as manager General meeting of 30-06-2018 · Gazette deed
Registered office moved from Berchem to Hove The registered office moved from Troyentenhoflaan 22, 2600 Berchem to Onderwijsstraat 8, 2540 Hove · Board meeting of 10-07-2017 · Gazette deed
Incorporation published on 29-02-2008 · Gazette deed
All 33 events

Official details

Source: KBO
Status
Active since 23-01-2008Normal situation
Activity
“Hetzetelenincommissiesenorganenwaarhetwettelijkdiplomavanartsofeenbijzondere beroepstitelvoorvereistis” (deed in Dutch)From the articles, 7 activities1 activity on the establishment unit
Establishment unit
2.190.991.4582540 Hove, registered on 23-01-2008
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €420,000estimated
€548,094▼ 1.2%
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on DR. L. ONKELINX

DR. L. ONKELINX files the micro format. That format states no turnover. The gross margin rose from €150,746 in 2008 to €168,510 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. L. ONKELINX

What is the company number of DR. L. ONKELINX?
The company number of DR. L. ONKELINX is 0895.851.319. The VAT number is the same number with BE in front: BE 0895.851.319.
Where is DR. L. ONKELINX based?
The registered office is at Onderwijsstraat 8, 2540 Hove.Company details
What is the legal form of DR. L. ONKELINX?
DR. L. ONKELINX is a private limited company (BV).
When was DR. L. ONKELINX founded?
DR. L. ONKELINX was founded on 23-01-2008.
Is DR. L. ONKELINX still active?
Yes, DR. L. ONKELINX is an active enterprise in the KBO register.
What is the turnover of DR. L. ONKELINX?
The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €168,510 and 2,459 comparable companies of the same size. It probably lies between €280,000 and €650,000. It is a rough estimate.Financials
Is DR. L. ONKELINX profitable?
In financial year 2025, DR. L. ONKELINX made a profit of €107,126.
Where can I find the annual accounts of DR. L. ONKELINX?
DR. L. ONKELINX filed 18 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. L. ONKELINX due?
DR. L. ONKELINX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.